- Home
- ADXN vs AIMD Comparison
ADXN vs AIMD Comparison
Compare ADXN & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- AIMD
- Stock Information
- Founded
- ADXN 2002
- AIMD 1984
- Country
- ADXN Switzerland
- AIMD United States
- Employees
- ADXN N/A
- AIMD N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- AIMD Health Care
- Exchange
- ADXN Nasdaq
- AIMD Nasdaq
- Market Cap
- ADXN 8.0M
- AIMD 8.5M
- IPO Year
- ADXN N/A
- AIMD N/A
- Fundamental
- Price
- ADXN $7.52
- AIMD $0.62
- Analyst Decision
- ADXN Strong Buy
- AIMD
- Analyst Count
- ADXN 1
- AIMD 0
- Target Price
- ADXN $30.00
- AIMD N/A
- AVG Volume (30 Days)
- ADXN 11.6K
- AIMD 227.7K
- Earning Date
- ADXN 03-24-2025
- AIMD 03-07-2025
- Dividend Yield
- ADXN N/A
- AIMD N/A
- EPS Growth
- ADXN N/A
- AIMD N/A
- EPS
- ADXN 0.06
- AIMD N/A
- Revenue
- ADXN $701,260.00
- AIMD $40,633.00
- Revenue This Year
- ADXN N/A
- AIMD N/A
- Revenue Next Year
- ADXN N/A
- AIMD N/A
- P/E Ratio
- ADXN $0.96
- AIMD N/A
- Revenue Growth
- ADXN N/A
- AIMD N/A
- 52 Week Low
- ADXN $6.67
- AIMD $0.40
- 52 Week High
- ADXN $27.90
- AIMD $3.10
- Technical
- Relative Strength Index (RSI)
- ADXN 48.90
- AIMD 47.20
- Support Level
- ADXN $6.67
- AIMD $0.56
- Resistance Level
- ADXN $7.80
- AIMD $0.77
- Average True Range (ATR)
- ADXN 0.39
- AIMD 0.06
- MACD
- ADXN 0.04
- AIMD -0.01
- Stochastic Oscillator
- ADXN 62.04
- AIMD 28.67
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.